Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125811741 | 12581174 | 1 | I | 2016 | 20160712 | 20160721 | 20160721 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059511 | BRISTOL MYERS SQUIBB | 0.00 | M | Y | 97.52000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125811741 | 12581174 | 1 | PS | ELIQUIS | APIXABAN | 1 | Unknown | 5 MG, QD | U | 202155 | 5 | MG | QD | ||||||
| 125811741 | 12581174 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | Oral | 0.5 MG, BID | M26213 | 0 | .5 | MG | CAPSULE | BID | |||||
| 125811741 | 12581174 | 3 | C | LANOXIN | DIGOXIN | 1 | Unknown | 0.25 MG, QD | U | 0 | .25 | MG | QD | ||||||
| 125811741 | 12581174 | 4 | C | LASIX | FUROSEMIDE | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 125811741 | 12581174 | 5 | C | ALDACTONE | SPIRONOLACTONE | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 125811741 | 12581174 | 6 | C | COREG | CARVEDILOL | 1 | Unknown | 3.125 MG, BID | U | 0 | 3.125 | MG | BID | ||||||
| 125811741 | 12581174 | 7 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 125811741 | 12581174 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125811741 | 12581174 | 1 | Product used for unknown indication |
| 125811741 | 12581174 | 2 | Atrial fibrillation |
| 125811741 | 12581174 | 3 | Cardiac disorder |
| 125811741 | 12581174 | 4 | Polyuria |
| 125811741 | 12581174 | 5 | Cardiac disorder |
| 125811741 | 12581174 | 6 | Cardiac disorder |
| 125811741 | 12581174 | 7 | Pain |
| 125811741 | 12581174 | 8 | Blood potassium |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125811741 | 12581174 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125811741 | 12581174 | Abasia | |
| 125811741 | 12581174 | Discomfort | |
| 125811741 | 12581174 | Gait disturbance | |
| 125811741 | 12581174 | Immobilisation prolonged | |
| 125811741 | 12581174 | Insomnia | |
| 125811741 | 12581174 | Muscular weakness | |
| 125811741 | 12581174 | Off label use | |
| 125811741 | 12581174 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125811741 | 12581174 | 2 | 2015 | 0 |